NVCR $78.90

0.38 (0.5%)


NVCR Profile

MEMBERSHIP
--
SECTOR
Health Care
MARKET CAPITALIZATION

$8 Billion

Mid-Cap
NovoCure Ltd serves in the healthcare sector of United States. Its business involves commercial stage oncology operations involving therapies to cure critical tumors. Its key offering is the TTFields therapy, which is a low-toxicity anti-mitotic treatment that uses low-intensity, intermediate frequency, alternating electric fields to exert physical forces on molecules inside cancer cells, thereby leading to cancer cell death. NovoCure derives its major revenues in the United States, through the sale of TTFields delivery system, which includes a portable electric field generator, transducer arrays, rechargeable batteries, and accessories.

NVCR Earnings

EPS

0.02

P/E

0.00

Q2 Earnings for Apr, May & Jun

Thu, Jul 25, 2019

Since Earnings Report

NVCR +11.1%

Q3 Earnings for Jul, Aug & Sep

Thu, Oct 31, 2019

Since Earnings Report

NVCR +6.2%

NVCR Dividend

Dividend Yield

0.00%

Dividend Rate

$0.00

Ex-Dividend Date

--

Dividend Pay Date

--

Dividend Frequency

--

Dividend Payments

--

NVCR Charts

52W Low $28.83
52W High $98.70
All-Time $98.70


NVCR Industry Competitors


MEDICAL EQUIPMENT & DEVICES
Medtronic
Abbott Laboratories
Thermo Fisher Scientific
Danaher
Stryker
Becton Dickinson
Intuitive Surgical
Boston Scientific
Edwards Lifesciences
Illumina



Symbol MC DY Price Day YTD
NVCR $7.85 0.00% $78.90 -0.5% 141.1%





Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com



    TOP    

©2019 Symbol Surfing All Rights Reserved.

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Cookies Policy Terms Of Service Privacy Policy